Dynamics in Post-pandemic Global Seasonal Influenza Vaccines Therapeutics Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ668891 No. of Pages: 133 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Seasonal Influenza Vaccines Therapeutics market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Seasonal Influenza Vaccines Therapeutics market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Paediatrics Adolescence Adults Elderly Segmented by End User/Segment Hospitals Clinics Others Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey GSK Solvay Sinovac Biotech Shanghai Institute of Biological Products Co., Ltd. Sanofi-Pasteur Novartis MedImmune Hualan Biological Engineering CSL Changchun Institute of Biological Products Co., Ltd.
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Seasonal Influenza Vaccines Therapeutics Market Status and Forecast (2016-2027)
1.3.2 Global Seasonal Influenza Vaccines Therapeutics Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Seasonal Influenza Vaccines Therapeutics Supply by Company
2.1 Global Seasonal Influenza Vaccines Therapeutics Sales Volume by Company
2.2 Global Seasonal Influenza Vaccines Therapeutics Sales Value by Company
2.3 Global Seasonal Influenza Vaccines Therapeutics Price by Company
2.4 Seasonal Influenza Vaccines Therapeutics Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Seasonal Influenza Vaccines Therapeutics Market Status by Category
3.1 Seasonal Influenza Vaccines Therapeutics Category Introduction
3.1.1 Paediatrics
3.1.2 Adolescence
3.1.3 Adults
3.1.4 Elderly
3.2 Global Seasonal Influenza Vaccines Therapeutics Market by Category
3.2.1 Global Seasonal Influenza Vaccines Therapeutics Sales Volume by Category (2016-2021)
3.2.2 Global Seasonal Influenza Vaccines Therapeutics Sales Value by Category (2016-2021)
3.2.3 Global Seasonal Influenza Vaccines Therapeutics Price by Category (2016-2021)
3.3 North America: by Category
3.4 Europe: by Category
3.5 Asia Pacific: by Category
3.6 Central & South America: by Category
3.7 Middle East & Africa: by Category
4 Global and Regional Seasonal Influenza Vaccines Therapeutics Market Status by End User/Segment
4.1 Seasonal Influenza Vaccines Therapeutics Segment by End User/Segment
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Seasonal Influenza Vaccines Therapeutics Market by End User/Segment
4.2.1 Global Seasonal Influenza Vaccines Therapeutics Sales Volume by End User/Segment (2016-2021)
4.2.2 Global Seasonal Influenza Vaccines Therapeutics Sales Value by End User/Segment (2016-2021)
4.2.3 Global Seasonal Influenza Vaccines Therapeutics Price by End User/Segment (2016-2021)
4.3 North America: by End User/Segment
4.4 Europe: by End User/Segment
4.5 Asia Pacific: by End User/Segment
4.6 Central & South America: by End User/Segment
4.7 Middle East & Africa: by End User/Segment
5 Global Seasonal Influenza Vaccines Therapeutics Market Status by Region
5.1 Global Seasonal Influenza Vaccines Therapeutics Market by Region
5.1.1 Global Seasonal Influenza Vaccines Therapeutics Sales Volume by Region
5.1.2 Global Seasonal Influenza Vaccines Therapeutics Sales Value by Region
5.2 North America Seasonal Influenza Vaccines Therapeutics Market Status
5.3 Europe Seasonal Influenza Vaccines Therapeutics Market Status
5.4 Asia Pacific Seasonal Influenza Vaccines Therapeutics Market Status
5.5 Central & South America Seasonal Influenza Vaccines Therapeutics Market Status
5.6 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Status
6 North America Seasonal Influenza Vaccines Therapeutics Market Status
6.1 North America Seasonal Influenza Vaccines Therapeutics Market by Country
6.1.1 North America Seasonal Influenza Vaccines Therapeutics Sales Volume by Country (2016-2021)
6.1.2 North America Seasonal Influenza Vaccines Therapeutics Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Seasonal Influenza Vaccines Therapeutics Market Status
7.1 Europe Seasonal Influenza Vaccines Therapeutics Market by Country
7.1.1 Europe Seasonal Influenza Vaccines Therapeutics Sales Volume by Country (2016-2021)
7.1.2 Europe Seasonal Influenza Vaccines Therapeutics Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Seasonal Influenza Vaccines Therapeutics Market Status
8.1 Asia Pacific Seasonal Influenza Vaccines Therapeutics Market by Country
8.1.1 Asia Pacific Seasonal Influenza Vaccines Therapeutics Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Seasonal Influenza Vaccines Therapeutics Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Seasonal Influenza Vaccines Therapeutics Market Status
9.1 Central & South America Seasonal Influenza Vaccines Therapeutics Market by Country
9.1.1 Central & South America Seasonal Influenza Vaccines Therapeutics Sales Volume by Country (2016-2021)
9.1.2 Central & South America Seasonal Influenza Vaccines Therapeutics Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Status
10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market by Country
10.1.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Seasonal Influenza Vaccines Therapeutics Manufacturing Cost Analysis
11.5 Seasonal Influenza Vaccines Therapeutics Sales Channel and Distributors Analysis
11.5.1 Seasonal Influenza Vaccines Therapeutics Sales Channel
11.5.2 Seasonal Influenza Vaccines Therapeutics Distributors
11.6 Seasonal Influenza Vaccines Therapeutics Downstream Major Buyers
12 Global Seasonal Influenza Vaccines Therapeutics Market Forecast by Category and by End User/Segment
12.1 Global Seasonal Influenza Vaccines Therapeutics Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Seasonal Influenza Vaccines Therapeutics Forecast by Category
12.2.1 Global Seasonal Influenza Vaccines Therapeutics Sales Volume Forecast by Category
12.2.2 Global Seasonal Influenza Vaccines Therapeutics Sales Value Forecast by Category
12.2.3 Global Seasonal Influenza Vaccines Therapeutics Price Forecast by Category
12.3 Global Seasonal Influenza Vaccines Therapeutics Forecast by End User/Segment
12.3.1 Global Seasonal Influenza Vaccines Therapeutics Sales Volume Forecast by End User/Segment
12.3.2 Global Seasonal Influenza Vaccines Therapeutics Sales Value Forecast by End User/Segment
12.3.3 Global Seasonal Influenza Vaccines Therapeutics Price Forecast by End User/Segment
13 Global Seasonal Influenza Vaccines Therapeutics Market Forecast by Region/Country
13.1 Global Seasonal Influenza Vaccines Therapeutics Market Forecast by Region (2022-2027)
13.1.1 Global Seasonal Influenza Vaccines Therapeutics Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Seasonal Influenza Vaccines Therapeutics Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 GSK
14.1.1 Company Information
14.1.2 Seasonal Influenza Vaccines Therapeutics Product Introduction
14.1.3 GSK
Seasonal Influenza Vaccines Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 Solvay
14.2.1 Company Information
14.2.2 Seasonal Influenza Vaccines Therapeutics Product Introduction
14.2.3 Solvay
Seasonal Influenza Vaccines Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Sinovac Biotech
14.3.1 Company Information
14.3.2 Seasonal Influenza Vaccines Therapeutics Product Introduction
14.3.3 Sinovac Biotech
Seasonal Influenza Vaccines Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Shanghai Institute of Biological Products Co., Ltd.
14.4.1 Company Information
14.4.2 Seasonal Influenza Vaccines Therapeutics Product Introduction
14.4.3 Shanghai Institute of Biological Products Co., Ltd.
Seasonal Influenza Vaccines Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 Sanofi-Pasteur
14.5.1 Company Information
14.5.2 Seasonal Influenza Vaccines Therapeutics Product Introduction
14.5.3 Sanofi-Pasteur
Seasonal Influenza Vaccines Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 Novartis
14.6.1 Company Information
14.6.2 Seasonal Influenza Vaccines Therapeutics Product Introduction
14.6.3 Novartis
Seasonal Influenza Vaccines Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
14.7 MedImmune
14.7.1 Company Information
14.7.2 Seasonal Influenza Vaccines Therapeutics Product Introduction
14.7.3 MedImmune
Seasonal Influenza Vaccines Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.7.4 SWOT Analysis
14.8 Hualan Biological Engineering
14.8.1 Company Information
14.8.2 Seasonal Influenza Vaccines Therapeutics Product Introduction
14.8.3 Hualan Biological Engineering
Seasonal Influenza Vaccines Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.8.4 SWOT Analysis
14.9 CSL
14.9.1 Company Information
14.9.2 Seasonal Influenza Vaccines Therapeutics Product Introduction
14.9.3 CSL
Seasonal Influenza Vaccines Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.9.4 SWOT Analysis
14.10 Changchun Institute of Biological Products Co., Ltd.
14.10.1 Company Information
14.10.2 Seasonal Influenza Vaccines Therapeutics Product Introduction
14.10.3 Changchun Institute of Biological Products Co., Ltd.
Seasonal Influenza Vaccines Therapeutics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.10.4 SWOT Analysis
15 Conclusion
16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com